A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis

Completed · Phase 4 · Has a placebo group

Conditions studied: Conjunctivitis, Allergic

In brief

This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to artificial tears (placebo) in the prevention of ocular itching associated with allergic conjunctivitis.

Key facts

Study ID

NCT01470118

Run by

Allergan

People needed

127

Starts

2011-10-01

Expected to finish

2011-12-01

Last updated by the study team

2013-02-21

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of eye allergies within the past 24 months
• Willing to not wear contact lenses at least 72 hours prior to the study start and during the study period

You may not qualify if…

• Current eye infection
• Eye surgery within 3 months or vision correction surgery within 6 months
• Any planned surgery during the study or 30 days after the study

Where it is running

• Study site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.